Finance Home - My Yahoo - Yahoo! - Help

Thursday, December 3, 2009, 12:19AM ET - U.S. Markets open in 9 hours and 11 minutes. Dow  0.18% Nasdaq  0.42%

Isis Pharmaceuticals, Inc. (ISIS)

On Dec 2: 10.64   0.06 (0.57%)

MORE ON ISIS

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Nov 30, 2009 • Biotech Calendar: Key Dates for December at TheStreet.com (Mon, Nov 30) Wed, Nov 25, 2009 • Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate at Seeking Alpha (Wed, Nov 25) Tue, Nov 24, 2009 • Isis Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference PR Newswire (Tue, Nov 24) Mon, Nov 23, 2009 • Genzyme's Very Bad Year at Seeking Alpha (Mon, Nov 23) • 5 Superball Stocks at Motley Fool (Mon, Nov 23) • Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders PR Newswire (Mon, Nov 23) Thu, Nov 19, 2009 • Stocks Doing Right By Shareholders at Motley Fool (Thu, Nov 19) • Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation PR Newswire (Thu, Nov 19) Wed, Nov 18, 2009 • Drug Lowers Cholesterol; Stock Follows at Motley Fool (Wed, Nov 18) • Genzyme Drops Kidney-Drug Plans Amid Pileup of Bad News at The Wall Street Journal Online (Wed, Nov 18) Tue, Nov 17, 2009 • [$$] Activity Jumps in Biotech and Drug Firms at The Wall Street Journal Online (Tue, Nov 17) • Tuesday Options Recap at Seeking Alpha (Tue, Nov 17) • Bulls Speculate On Long Dowdy Duds at Forbes.com (Tue, Nov 17) • Tuesday Options Update: ISIS, DTV, SINA & XOM at Seeking Alpha (Tue, Nov 17) • UPDATE - Isis drug meets all study goals; filing delayed at Reuters (Tue, Nov 17) • Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz at TheStreet.com (Tue, Nov 17) • ISIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Nov 17) • Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at AHA Business Wire (Tue, Nov 17) Mon, Nov 16, 2009 • ISIS' Short-Term Trends Demonstrate When Technical Analysis Is Important at Seeking Alpha (Mon, Nov 16) Wed, Nov 11, 2009 • Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA PR Newswire (Wed, Nov 11) Older Headlines - Download Recent Headlines View headlines from: Wed, Nov 11, 2009Wed, Nov 4, 2009Wed, Oct 28, 2009Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009Wed, Sep 9, 2009 Add ISIS News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage